Advertisement
Advertisement

CMMB

CMMB logo

Chemomab Therapeutics Ltd. - ADR

1.89
USD
Sponsored
-0.04
-2.07%
Aug 10, 15:59 UTC -4
Closed
exchange

After-Market

1.87

-0.02
-1.06%

Chemomab Therapeutics Ltd. - ADR Profile

About

Chemomab Ltd. is a clinical-stage biotech company. It focuses on the discovery and development of innovative therapeutics for fibrosis-related diseases with high unmet need. The company's product pipeline includes CM-101. Chemomab Ltd., formerly known as Anchiano Therapeutics Ltd., is based in TEL-AVIV, Israel.

Info & Links

CEO

Adi Mor

Headquarters

10 HABARZEL STREET, BUILDING C, 10TH FLOOR
TEL AVIV, L3 6158101, ISRAEL

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.chemomab.com

Auditor

Somekh Chaikin

Share holders

7

Employees

10

Chemomab Therapeutics Ltd. - ADR Statistics

Valuation Measures

Market Capitalization2

13.70M

Enterprise Value

7.80M

Enterprise Value/EBITDA(ttm)

-0.98

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

1.30

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-89.03%

Return on Invested Capital(ttm)

-68.48%

Return on Assets(ttm)

-79.68%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

--

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-7.93M

Net Income Available to Common(ttm)

-7.45M

Diluted EPS(ttm)

-2.22

Share Statistics

Beta (5Y Monthly)

0.65

52-Week Change

-51.28%

S&P 500 52-Week Change

21.65%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

--

Dividend Yield

0.00%

Float4

6.34M

% Held by Insiders

11.91%

% Held by Institutions

46.05%

Balance Sheet

Total Cash(mrq)

8.04M

Total Cash Per Share(mrq)

--

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

10.31%

Quick Ratio(mrq)

10.31%

Book Value Per Share(mrq)

1.49

Cash Flow

Operating Cash Flow Per Share(ytd)

--

Free Cash Flow(ytd)

0.00

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement